Li, Ling et al. published their research in Organic Letters in 2021 |CAS: 89-77-0

The Article related to amine hydroxyketone regioselective diastereoselective tandem heyns rearrangement oxidation, imino ketone preparation, hydroxyketone aminoalc regioselective diastereoselective tandem heyns rearrangement oxidation, ketal preparation and other aspects.Quality Control of 2-Amino-4-chlorobenzoic acid

On September 3, 2021, Li, Ling; Zhang, Shiqi; Deng, Xiongfei; Li, Guangxun; Tang, Zhuo; Zhao, Gang published an article.Quality Control of 2-Amino-4-chlorobenzoic acid The title of the article was Preparation and Application of α-Imino Ketones through One-Pot Tandem Reactions Based on Heyns Rearrangement. And the article contained the following:

A metal-free and operationally simple strategy was developed to generate α-imino ketones with high regioselectivity. Meanwhile, the method allowed for the preparation of various N,O-ketals with high regioselectivities and diastereoselectivities through cascade reactions in one pot. The experimental process involved the reaction of 2-Amino-4-chlorobenzoic acid(cas: 89-77-0).Quality Control of 2-Amino-4-chlorobenzoic acid

The Article related to amine hydroxyketone regioselective diastereoselective tandem heyns rearrangement oxidation, imino ketone preparation, hydroxyketone aminoalc regioselective diastereoselective tandem heyns rearrangement oxidation, ketal preparation and other aspects.Quality Control of 2-Amino-4-chlorobenzoic acid

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Li, Bowen et al. published their research in Angewandte Chemie, International Edition in 2019 |CAS: 98946-18-0

The Article related to enantioselective alpha aryl carboxamide preparation palladium catalyst, cross coupling alpha bromo carboxamide arylboronic acid phosphorus ligand, asymmetric catalysis, cross-coupling, palladium, phosphorus ligands, transmetalation and other aspects.Electric Literature of 98946-18-0

Li, Bowen; Li, Tiejun; Aliyu, Muinat A.; Li, Zhen Hua; Tang, Wenjun published an article in 2019, the title of the article was Enantioselective Palladium-Catalyzed Cross-Coupling of α-Bromo Carboxamides and Aryl Boronic Acids.Electric Literature of 98946-18-0 And the article contains the following content:

We herein report an enantioselective palladium-catalyzed cross-coupling between α-bromo carboxamides and aryl boronic acids, generating a series of chiral α-aryl carboxamides in good yields and excellent enantioselectivities. The development of a chiral P,P=O ligand was critical in overcoming the second transmetalation issue and allows the first asym. palladium-catalyzed coupling of α-bromo carbonyl compounds The experimental process involved the reaction of tert-Butyl trichloroacetimidate(cas: 98946-18-0).Electric Literature of 98946-18-0

The Article related to enantioselective alpha aryl carboxamide preparation palladium catalyst, cross coupling alpha bromo carboxamide arylboronic acid phosphorus ligand, asymmetric catalysis, cross-coupling, palladium, phosphorus ligands, transmetalation and other aspects.Electric Literature of 98946-18-0

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Buhr, Wilm et al. published their patent in 2012 |CAS: 82711-97-5

The Article related to sulfonaminoquinoline preparation hepcidin antagonist treatment iron metabolic disorder, dioxothiatriazaphenanthrene dioxothiadiazachrysene dioxoazacyclopentanaphthalene dioxothiatriazachrysene preparation anemia hepcidin antagonist and other aspects.Electric Literature of 82711-97-5

On August 23, 2012, Buhr, Wilm; Burckhardt, Susanna; Duerrenberger, Franz; Funk, Felix; Geisser, Peter Otto; Corden, Vincent Anthony; Courtney, Stephen Martin; Davenport, Tara; Slack, Mark; Ridgill, Mark Peter; Yarnold, Christopher John; Dawson, Graham; Boyce, Susan; Ellenbroek, Albertus Antonius published a patent.Electric Literature of 82711-97-5 The title of the patent was Novel sulfonaminoquinoline derivatives as hepcidin antagonists and their preparation and use in the treatment of iron metabolic disorders. And the patent contained the following:

The invention is related to the preparation of title compounds I [R1-6 = independently H, halo, CN, (un)substituted aroxy, heterocyclyl, etc.; R7 = H, (un)substituted alk(en/yn)yl, aryl, etc.; R8 = H, NH2 and derivatives, OH and derivatives, etc.; or R6 and R8 together form a residue II or III; X = C, N; R9-12 = independently H, NO2, CO2H and derivatives, etc.; R13 = H, (un)substituted aryl, acyl, alkyl, etc.; R14, R15 = H, halo, (un)substituted alkoxycarbonyl, aminosulfonyl, etc.] and their pharmaceutically acceptable salts as hepcidin antagonists, pharmaceutical compositions containing them, and to their use as medicaments, in particular for treating iron metabolism disorders, for example, iron deficiency diseases and anemias, in particular anemias combined with chronic inflammation diseases and anemia of inflammation. Thus, reaction of 7-methyl-8-nitroquinoline with 1,1-dimethoxy-N,N-dimethylmethanamine, oxidation of dimethyl[(E)-2-(8-nitroquinolin-7-yl)ethenyl]amine, reductive amination of 8-nitroquinoline-7-carboxaldehyde with aniline, Pd/C hydrogenation of N-[(8-nitroquinolin-7-yl)methyl]phenylamine and cyclization of [7-[(phenylamino)methyl]quinolin-8-yl]amine with 1-[(1H-imidazol-1-yl)sulfonyl]-3-methyl-1H-imidazol-3-ium trifluoromethanesulfonate gave IV. Selected I were evaluated for their hepcidin antagonistic activity. From the assay, it was determined that compound IV exhibited an IC50 value of 0.46 μM towards ferroportin. The experimental process involved the reaction of 5-Fluoro-2-nitrobenzene-1-sulfonyl chloride(cas: 82711-97-5).Electric Literature of 82711-97-5

The Article related to sulfonaminoquinoline preparation hepcidin antagonist treatment iron metabolic disorder, dioxothiatriazaphenanthrene dioxothiadiazachrysene dioxoazacyclopentanaphthalene dioxothiatriazachrysene preparation anemia hepcidin antagonist and other aspects.Electric Literature of 82711-97-5

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Isherwood, Matthew L. et al. published their research in Tetrahedron: Asymmetry in 2012 |CAS: 14602-86-9

The Article related to methyltrifluoromethylphenylsulfonylhexahydroepiminocycloheptaindole preparation chem resolution, substitution hydrolysis, butylbromohexahydroepiminocycloheptaindolecarboxylate menthyl chloroformate separation hydrolysis methylation and other aspects.Quality Control of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate

On December 15, 2012, Isherwood, Matthew L.; Guzzo, Peter R.; Henderson, Alan J.; Hsia, Ming Min; Kaur, Jagjit; Nacro, Kassoum; Narreddula, Venkateswara R.; Panduga, Shailaja; Pathak, Rashmi; Shimpukade, Bharat; Tan, Valentina; Xiang, Kai; Qiang, Zhu; Ghosh, Animesh published an article.Quality Control of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate The title of the article was An efficient synthesis of (7S,10R)-2-bromo-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohepta[b]indole: application in the preparation and structural confirmation of a potent 5-HT6 antagonist. And the article contained the following:

(7S,10R)-5-Methyl-2-((3-(trifluoromethyl)phenyl)sulfonyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohepta[b]indole I is a potent 5-HT6 antagonist (h5-HT6Ki = 1.5 nM) which is derived from an epiminocyclohept[b]indole scaffold. In order to synthesize I on a multi-gram scale to support advanced biol. testing, an efficient chiral resolution of the intermediate tert-Bu 2-bromo-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohepta[b]indole-11-carboxylate II was developed. After derivatizing II with (1R)-(-)-menthyl chloroformate it was found that a single diastereomer III could be isolated by selective precipitation from n-hexane. The absolute stereochem. of III was determined by X-ray crystallog. and the structure was confirmed as (7S,10R)-tert-Bu 2-bromo-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohepta[b]indole-11-carboxylate. Removal of the chiral auxiliary under basic conditions afforded intermediate II in >99% enantiomeric purity and with 80% yield based on recovery from the racemic compound II. Intermediate enantiomer II was used successfully to synthesize 5-HT6 antagonist I on a multi-gram scale. The experimental process involved the reaction of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate(cas: 14602-86-9).Quality Control of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate

The Article related to methyltrifluoromethylphenylsulfonylhexahydroepiminocycloheptaindole preparation chem resolution, substitution hydrolysis, butylbromohexahydroepiminocycloheptaindolecarboxylate menthyl chloroformate separation hydrolysis methylation and other aspects.Quality Control of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Gui, Qing-Wen et al. published their research in Chemistry – An Asian Journal in 2022 |CAS: 89-77-0

The Article related to ring fused quinazolinone preparation, alkenyl quinazolinone visible light cascade difluoromethylation cyclization green chem, cascade radical reactions, difluoromethylation, dimethyl carbonate, metal-free, ring-fused quinazolinones and other aspects.Electric Literature of 89-77-0

On January 3, 2022, Gui, Qing-Wen; Teng, Fan; Yang, Hao; Xun, Changping; Huang, Wen-Jie; Lu, Zi-Qin; Zhu, Meng-Xue; Ouyang, Wen-Tao; He, Wei-Min published an article.Electric Literature of 89-77-0 The title of the article was Visible-Light Photosynthesis of CHF2/CClF2/CBrF2-Substituted Ring-fused Quinazolinones in Dimethyl Carbonate. And the article contained the following:

With eco-friendly and sustainable CO2-derived di-Me carbonate as the sole solvent, the visible-light-induced cascade radical reactions have been established as a green and efficient tool for constructing various CHF2/CClF2/CBrF2-substituted ring-fused quinazolinones. The experimental process involved the reaction of 2-Amino-4-chlorobenzoic acid(cas: 89-77-0).Electric Literature of 89-77-0

The Article related to ring fused quinazolinone preparation, alkenyl quinazolinone visible light cascade difluoromethylation cyclization green chem, cascade radical reactions, difluoromethylation, dimethyl carbonate, metal-free, ring-fused quinazolinones and other aspects.Electric Literature of 89-77-0

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Tomari, Masazumi et al. published their patent in 1975 |CAS: 59833-69-1

The Article related to analgesic isoindole, antiinflammatory isoindole, isoindole carboxyalkylphenyl, cyclization bischloromethylbenzene carboxyalkylaniline, chloromethylbenzene dicyclization aniline, aminophenylalkanoate cyclization bischloromethylbenzene and other aspects.Product Details of 59833-69-1

On November 27, 1975, Tomari, Masazumi; Miyamatsu, Hiroki; Kiyota, Keiichi; Yasuno, Akio published a patent.Product Details of 59833-69-1 The title of the patent was 2-(Alkoxycarbonylmethylphenyl)-1,3-dihydroisoindoles. And the patent contained the following:

Dihydroisoindoles I (X = H, halo; R = H, Me; R1 = C1-4 alkyl) or their salts are prepared by cyclizing o-(ClCH2)2C6H4 (II) with aminophenylacetate esters III (R2 = C1-4 alkyl). I have antiinflammatory and analgesic effects (no data). Thus, 5.24 g II was refluxed with 6 g III (X = 2-Cl, x = 5, R = H, R2 = Me) (IV) and 6.36 g Na2CO3 in DMF 4 hr to give 70% I (X = 2-Cl, x = 5, R = H, R1 = Me). The ester was hydrolyzed with KOH in MeOH to give 51.5% I (X = 2-Cl, x = 5, R = R1 = H), also prepared in 80% yield by heating II and IV with NaOH in MeOH. Similarly prepared were I (X, x, R, R1 given): 2-Cl, 5, Me, Me; 2-Cl, 5, Me, H; H, 4, H, Me; H, 4, H, H. The experimental process involved the reaction of Methyl 2-(3-amino-4-chlorophenyl)acetate(cas: 59833-69-1).Product Details of 59833-69-1

The Article related to analgesic isoindole, antiinflammatory isoindole, isoindole carboxyalkylphenyl, cyclization bischloromethylbenzene carboxyalkylaniline, chloromethylbenzene dicyclization aniline, aminophenylalkanoate cyclization bischloromethylbenzene and other aspects.Product Details of 59833-69-1

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Sun, Shuai-Shuai et al. published their research in Tetrahedron Letters in 2019 |CAS: 98946-18-0

The Article related to diamino diacid synthesis solid phase incorporation peptide disulfide bond, oxytocin mimic cyclic peptide solid phase synthesis oxidative cyclization, homoserine protection sulfonation substitution hydrolysis bromination thioalkylation and other aspects.Product Details of 98946-18-0

On April 25, 2019, Sun, Shuai-Shuai; Chen, Junyou; Zhao, Rui; Bierer, Donald; Wang, Jun; Fang, Ge-Min; Li, Yi-Ming published an article.Product Details of 98946-18-0 The title of the article was Efficient synthesis of a side-chain extended diaminodiacid for solid-phase synthesis of peptide disulfide bond mimics. And the article contained the following:

Solid-phase incorporation of diaminodiacids is one of the most effective approaches for synthesis of peptide disulfide bond mimics. One of a limitation of current diaminodiacid toolbox is that only four-atom linkage mimics are available that may not fully meet the activity optimization requirement. In this work, we developed a new diaminodiacid that contains a five-atom thioether (C-C-S-C-C) bridge for the first time. With this diaminodiacid in hand, we successfully obtained oxytocin containing new disulfide bond mimic by solid phase peptide synthesis. The experimental process involved the reaction of tert-Butyl trichloroacetimidate(cas: 98946-18-0).Product Details of 98946-18-0

The Article related to diamino diacid synthesis solid phase incorporation peptide disulfide bond, oxytocin mimic cyclic peptide solid phase synthesis oxidative cyclization, homoserine protection sulfonation substitution hydrolysis bromination thioalkylation and other aspects.Product Details of 98946-18-0

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Yu, Haiqing et al. published their research in European Journal of Medicinal Chemistry in 2016 |CAS: 99-60-5

The Article related to adamantyl anilinoquinazoline preparation epidermal growth factor receptor inhibitor, egfr inhibitor adamantyl anilinoquinazoline preparation, quinazoline adamantyl preparation egfr inhibitor, adamantyl, egfr, nsclc, quinazoline, t790m and other aspects.Computed Properties of 99-60-5

On March 3, 2016, Yu, Haiqing; Li, Yanxia; Ge, Yang; Song, Zhendong; Wang, Changyuan; Huang, Shanshan; Jin, Yue; Han, Xu; Zhen, Yuhong; Liu, Kexin; Zhou, Youwen; Ma, Xiaodong published an article.Computed Properties of 99-60-5 The title of the article was Novel 4-anilinoquinazoline derivatives featuring an 1-adamantyl moiety as potent EGFR inhibitors with enhanced activity against NSCLC cell lines. And the article contained the following:

With the aim of overcoming gefitinib resistance, a series of novel quinazoline derivatives bearing an adamantyl group on the aniline ring were synthesized as potent epidermal growth factor receptor (EGFR) inhibitors. Most of these analogs are comparable to gefitinib in their ability to inhibit non-small cell lung cancer (NSCLC) cell lines, and several also exhibited significantly enhanced anti-tumor potency. Specifically, compound I, with an IC50 value of 2.06 μM against A431 cells with the wild-type EGFR and of 0.009 μM against the gefitinib-sensitive cells, displayed approx. 5-fold higher potency than the lead compound to inhibit the cells harboring the EGFRT790M mutant. In addition, the mol. simulation and Western blot anal. results also indicated that these compounds effectively interfered with the EGFRT790M activity, and may serve as a new alternative structure to develop more effective antitumor agents. The experimental process involved the reaction of 2-Chloro-4-nitrobenzoic acid(cas: 99-60-5).Computed Properties of 99-60-5

The Article related to adamantyl anilinoquinazoline preparation epidermal growth factor receptor inhibitor, egfr inhibitor adamantyl anilinoquinazoline preparation, quinazoline adamantyl preparation egfr inhibitor, adamantyl, egfr, nsclc, quinazoline, t790m and other aspects.Computed Properties of 99-60-5

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Heppner, Philip D. et al. published their patent in 2003 |CAS: 38939-88-7

The Article related to imidazoquinoline aryl ether preparation immunomodulator antiviral antitumor, cytokine interferon tnf alpha biosynthesis inducer imidazoquinoline preparation, tumor necrosis factor alpha biosynthesis inducer imidazoquinoline preparation and other aspects.Recommanded Product: 2-Chloro-4-methyl-1-nitrobenzene

On November 13, 2003, Heppner, Philip D.; Charles, Leslie J.; Dellaria, Joseph F.; Merrill, Bryon A.; Mickelson, John W. published a patent.Recommanded Product: 2-Chloro-4-methyl-1-nitrobenzene The title of the patent was Preparation of aryl ether substituted imidazoquinolines as immune response modifiers. And the patent contained the following:

The title compounds [I; X = (CH2)2, CHEtCH2, etc.; R1 = alkenyl, aryl, R4-aryl; R2 = H, alkyl, alkenyl, etc.; R4 = alkyl, alkenyl which may be interrupted by one or more O atoms; R3 = H, alkyl; n = 0-4; R = alkyl, alkoxy, OH, etc.] that contain ether and aryl or alkenyl functionality at the 1-position, and are useful as immune response modifiers, were prepared E.g., a multi-step synthesis of I [X = (CH2)2; R1 = CH2CCH; R2 = H; n = 0] which showed the lowest effective concentration of 0.12 μM and 1.11 μM to induce biosynthesis of interferon α and TNFα in human cells, resp., was given. The compounds I can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases. The pharmaceutical composition comprising the compound I is claimed. The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).Recommanded Product: 2-Chloro-4-methyl-1-nitrobenzene

The Article related to imidazoquinoline aryl ether preparation immunomodulator antiviral antitumor, cytokine interferon tnf alpha biosynthesis inducer imidazoquinoline preparation, tumor necrosis factor alpha biosynthesis inducer imidazoquinoline preparation and other aspects.Recommanded Product: 2-Chloro-4-methyl-1-nitrobenzene

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Moselage, Marc et al. published their research in Angewandte Chemie, International Edition in 2017 |CAS: 452-75-5

The Article related to arylindazole decarbamoylative arylation alkylation ruthenium, arylpyrazole decarbamoylative arylation alkylation, ruthenium decarbamoylative arylation alkylation catalyst, c−c activation, amides, arylation, reaction mechanisms, ruthenium and other aspects.Computed Properties of 452-75-5

Moselage, Marc; Li, Jie; Kramm, Frederik; Ackermann, Lutz published an article in 2017, the title of the article was Ruthenium(II)-Catalyzed C-C Arylations and Alkylations: Decarbamoylative C-C Functionalizations.Computed Properties of 452-75-5 And the article contains the following content:

Ruthenium(II)biscarboxylate catalysis enabled selective C-C functionalizations by means of decarbamoylative C-C arylations. The versatility of the ruthenium(II) catalysis was reflected by widely applicable C-C arylations and C-C alkylations of aryl amides, as well as acids with modifiable pyrazoles, through facile organometallic C-C activation. The experimental process involved the reaction of 4-Chloro-2-fluorotoluene(cas: 452-75-5).Computed Properties of 452-75-5

The Article related to arylindazole decarbamoylative arylation alkylation ruthenium, arylpyrazole decarbamoylative arylation alkylation, ruthenium decarbamoylative arylation alkylation catalyst, c−c activation, amides, arylation, reaction mechanisms, ruthenium and other aspects.Computed Properties of 452-75-5

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics